Category: Federal Forum Posters
Purpose: A typical VA primary care provider with 1,200 patients only has sufficient availability to see each patient 2.5 times annually on average. Limited access may prevent veterans from obtaining optimal care. This includes comprehensive medication management, which clinical pharmacy specialists have qualifications to perform. Several providers at Robley Rex VA Medical Center are over capacity with assigned patients according to reports. The project aims to open provider access at Robley Rex by converting appointments from providers to pharmacists. This promotes pharmacist utilization to help patients reach individualized disease state goals and frees time for providers to address more acute needs.
Methods: Conversion of appointments from primary care providers to clinical pharmacy specialists will be conducted at three Robley Rex VA outpatient clinics with one pharmacist assigned to one provider at each clinic. From October 2018 through March 2019, each clinic will undergo project implementation for two consecutive months. The month before a clinic’s project implementation, patient eligibility for pharmacist appointments will be assessed based on need for chronic disease state management. Assessment will occur through review of provider return-to-clinic orders using an appointments planning tool and the last provider visit note in the electronic medical record. The scheduler will cancel provider appointments and schedule pharmacist appointments for eligible patients. Details of completed appointments will be recorded in spreadsheets and metrics associated with project endpoints will be analyzed. Data will be accessible only to those named in the protocol. Primary endpoints are provider minutes saved and number of slots opened for provider appointments. Secondary endpoints include numbers of the following: pharmacist appointments conducted, appointments converted for each indication (hypertension, hyperlipidemia, diabetes, smoking cessation, and an “other” category: asthma, chronic obstructive pulmonary disease, benign prostatic hyperplasia, heart failure, gout, thyroid disease, and vitamin D deficiency), face-to-face vs. telephone appointments, and pharmacist clinical interventions.
Results: not applicable
Conclusion: not applicable
Serene Macaraig– PGY1 Pharmacy Resident, Robley Rex VA Medical Center, Louisville, KY